Phylogenetic Analysis of the 2020 West Nile Virus (WNV) Outbreak in Andalusia (Spain).


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
05 05 2021
Historique:
received: 24 02 2021
revised: 29 04 2021
accepted: 03 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 7 8 2021
Statut: epublish

Résumé

During recent decades West Nile Virus (WNV) outbreaks have continuously occurred in the Mediterranean area. In August 2020 a new WNV outbreak affected 71 people with meningoencephalitis in Andalusia and six more cases were detected in Extremadura (south-west of Spain), causing a total of eight deaths. The whole genomes of four viruses were obtained and phylogenetically analyzed in the context of recent outbreaks. The Andalusian viral samples belonged to lineage 1 and were relatively similar to those of previous outbreaks which occurred in the Mediterranean region. Here we present a detailed analysis of the outbreak, including an extensive phylogenetic study. As part on this effort, we implemented a local Nextstrain server, which has become a constituent piece of regional epidemiological surveillance, wherein forthcoming genomes of environmental samples or, eventually, future outbreaks, will be included.

Identifiants

pubmed: 34063166
pii: v13050836
doi: 10.3390/v13050836
pmc: PMC8148183
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2020 Sep 24;10(1):15643
pubmed: 32973171
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Viruses. 2013 Nov 22;5(11):2825-39
pubmed: 24284876
J Clin Microbiol. 2014 Sep;52(9):3411-3
pubmed: 24951801
PLoS Negl Trop Dis. 2017 Nov 8;11(11):e0006078
pubmed: 29117195
Zh Mikrobiol Epidemiol Immunobiol. 2011 Mar-Apr;(2):29-37
pubmed: 21598612
Bioinformatics. 2016 Jul 1;32(13):1933-42
pubmed: 27153688
Euro Surveill. 2009 Aug 06;14(31):
pubmed: 19660244
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Clin Microbiol Infect. 2012 Dec;18(12):E541-4
pubmed: 23004685
Nucleic Acids Res. 2010 Jan;38(Database issue):D161-6
pubmed: 19858104
Nat Rev Genet. 2018 Jan;19(1):9-20
pubmed: 29129921
Euro Surveill. 2013 Sep 19;18(38):
pubmed: 24084339
Cell Microbiol. 2013 Oct;15(10):1688-706
pubmed: 23522008
J Hum Genet. 2020 Dec;65(12):1075-1082
pubmed: 32699345
Euro Surveill. 2016 Sep 15;21(37):
pubmed: 27684046
Methods Mol Biol. 2016;1374:23-54
pubmed: 26519399
Emerg Infect Dis. 2006 Apr;12(4):618-23
pubmed: 16704810
Emerg Infect Dis. 1999 Sep-Oct;5(5):643-50
pubmed: 10511520
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Annu Rev Entomol. 2008;53:61-81
pubmed: 17645411
Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):147-56
pubmed: 14986160
Ann Inst Pasteur (Paris). 1970 Feb;118(2):239-47
pubmed: 5461277
J Virol. 2004 Oct;78(19):10543-55
pubmed: 15367621
Genome Announc. 2017 Oct 26;5(43):
pubmed: 29074649
Euro Surveill. 2018 Apr;23(14):
pubmed: 29637890
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
Nat Med. 2004 Dec;10(12 Suppl):S98-109
pubmed: 15577938
Transbound Emerg Dis. 2019 Mar;66(2):617-621
pubmed: 30506625
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Enferm Infecc Microbiol Clin. 2015 Mar;33(3):197-205
pubmed: 24139129
Genomics Proteomics Bioinformatics. 2006 Nov;4(4):259-63
pubmed: 17531802
Biochem J. 2007 Feb 1;401(3):743-52
pubmed: 17067286
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Gen Virol. 2011 Nov;92(Pt 11):2512-2522
pubmed: 21775579
PLoS One. 2018 Nov 26;13(11):e0205801
pubmed: 30475820
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
J Hyg Epidemiol Microbiol Immunol. 1959;3:277-82
pubmed: 13796704
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
J Virol Methods. 2016 Oct;236:266-270
pubmed: 27481597
J Gen Virol. 2017 Apr;98(4):662-670
pubmed: 28475031

Auteurs

Carlos S Casimiro-Soriguer (CS)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.

Javier Perez-Florido (J)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.

Jose L Fernandez-Rueda (JL)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.

Irene Pedrosa-Corral (I)

Laboratorio de Referencia de Virus de Andalucía, Servicio de Microbiología, Hospital Virgen de las Nieves, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria, ibs.GRANADA, 18012 Granada, Spain.

Vicente Guillot-Sulay (V)

Laboratorio de Referencia de Virus de Andalucía, Servicio de Microbiología, Hospital Virgen de las Nieves, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria, ibs.GRANADA, 18012 Granada, Spain.

Nicola Lorusso (N)

Dirección General de Salud Pública y Ordenación Farmacéutica, Consejería de Salud y Familias, Junta de Andalucía, 41020, Sevilla, Spain.

Luis Javier Martinez-Gonzalez (LJ)

GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, 18016 Granada, Spain.

Jose M Navarro-Marí (JM)

Laboratorio de Referencia de Virus de Andalucía, Servicio de Microbiología, Hospital Virgen de las Nieves, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria, ibs.GRANADA, 18012 Granada, Spain.

Joaquin Dopazo (J)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013 Sevilla, Spain.
Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013 Sevilla, Spain.
ELIXIR.ES/FPS, Hospital Virgen del Rocio, 41013 Sevilla, Spain.

Sara Sanbonmatsu-Gámez (S)

Laboratorio de Referencia de Virus de Andalucía, Servicio de Microbiología, Hospital Virgen de las Nieves, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria, ibs.GRANADA, 18012 Granada, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH